Stonebridge Capital Management Inc Regeneron Pharmaceuticals, Inc. Transaction History

Stonebridge Capital Management Inc

$252 Million
Q3 2024

A detailed history of Stonebridge Capital Management Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Stonebridge Capital Management Inc holds 735 shares of REGN stock, worth $609,197. This represents 0.31% of its overall portfolio holdings.

Number of Shares

735

Previous 735 -0.0%

Holding current value

$609,197

Previous $773,000 -0.0%

% of portfolio

0.31%

Previous 0.33%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Dec 13, 2023	SELL	$692.45 - $844.37 $6,924 - $8,443	-10 Reduced 1.34%	735 $605,000
Q4 2022 Jan 06, 2023	SELL	$705.89 - $766.39 $123,530 - $134,118	-175 Reduced 19.02%	745 $538,000
Q2 2020 Jul 07, 2020	SELL	$493.32 - $643.92 $24,666 - $32,195	-50 Reduced 5.15%	920 $560,000
Q1 2020 May 20, 2020	SELL	$336.18 - $494.43 $16,809 - $24,721	-50 Reduced 4.9%	970 $474,000
Q4 2019 Jan 02, 2020	SELL	$274.13 - $376.51 $20,559 - $28,238	-75 Reduced 6.85%	1,020 $383,000
Q3 2019 Oct 02, 2019	SELL	$273.46 - $318.39 $88,601 - $103,158	-324 Reduced 22.83%	1,095 $304,000
Q2 2019 Jul 12, 2019	SELL	$299.6 - $414.82 $221,704 - $306,966	-740 Reduced 34.28%	1,419 $445,000
Q1 2019 May 02, 2019	SELL	$372.08 - $439.57 $22,324 - $26,374	-60 Reduced 2.7%	2,159 $887,000
Q4 2018 Jan 25, 2019	SELL	$335.82 - $403.04 $8,395 - $10,076	-25 Reduced 1.11%	2,219 $829,000
Q3 2018 Oct 17, 2018	SELL	$351.14 - $408.51 $89,540 - $104,170	-255 Reduced 10.2%	2,244 $907,000
Q2 2018 Jul 06, 2018	BUY	$284.6 - $344.99 $47,243 - $57,268	166 Added 7.12%	2,499 $902,000
Q1 2018 Apr 16, 2018	BUY	$315.82 - $393.78 $191,071 - $238,236	605 Added 35.01%	2,333 $750,000
Q4 2017 Jan 29, 2018	BUY	$358.63 - $469.95 $619,712 - $812,073	1,728	1,728 $634,000

Others Institutions Holding REGN

# of Institutions

1,483

Shares Held

85.7M

Call Options Held

908K

Put Options Held

1.3M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $88.8B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonebridge Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Stonebridge Capital Management Inc with notifications on news.

Account

Stonebridge Capital Management Inc Regeneron Pharmaceuticals, Inc. Transaction History